(2S,4S)-1-(BENZYLOXYCARBONYL)-4-(TERT-BUTOXYCARBONYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 5g

Ethyl 5-hydroxy-6-iodonicotinate, 95.0%, 250mg

tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate, 97.0%, 50mg

1-(3,4-Dichlorophenyl)-1H-imidazole-4-carboxylic acid, 97%, 250mg

Mevastatin, >95%, 500g

PFA-Dose, 1000 ml, 1 Stück

1-(Pyridin-4-yl)butan-1-one, 95.0%, 1g

2,5-Dibromopyridine>99.0%(GC)5g

(3R,4S,5S,6R)-6-(hydroxymethyl)-2-methoxy-2-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol, 98%, 5mg

1,2-Ethanediamine, N1-[2-(3,4-dichlorophenyl)ethyl]-N1,N2,N2-trimethyl-, hydrobromide (1:2), 50mg

(S)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid, 95.0%, 10g

Copper(II) fluoride, anhydrous, 99.0%, 100g

tert-Butyl thiazol-4-ylcarbamate, 95.0%, 100g